Time-dependent effects of hormone-deprivation therapy on prostate metabolism as detected by combined magnetic resonance imaging and 3D magnetic resonance spectroscopic imaging.
about
The potential of ¹¹C-acetate PET for monitoring the Fatty acid synthesis pathway in TumorsMetabolic Imaging in Humans.Semi-parametric time-domain quantification of HR-MAS data from prostate tissueEffect on therapeutic ratio of planning a boosted radiotherapy dose to the dominant intraprostatic tumour lesion within the prostate based on multifunctional MR parameters.Prostate cancer metabolite quantification relative to water in 1H-MRSI in vivo at 3 Tesla.Magnetic resonance spectroscopy in metabolic and molecular imaging and diagnosis of cancerPharmaco-metabolomics: an emerging "omics" tool for the personalization of anticancer treatments and identification of new valuable therapeutic targets.Advances in uroradiological imaging.Combined magnetic resonance imaging and spectroscopic imaging approach to molecular imaging of prostate cancer.Novel Approaches to Imaging Tumor MetabolismMetabolic tumor imaging using magnetic resonance spectroscopy.Functional imaging for prostate cancer: therapeutic implications.Therapeutic targets and biomarkers identified in cancer choline phospholipid metabolism.Prostate cancer: correlation of MR imaging and MR spectroscopy with pathologic findings after radiation therapy-initial experience.Choline metabolism in cancer: implications for diagnosis and therapy.Current role and future perspectives of magnetic resonance spectroscopy in radiation oncology for prostate cancer.Metabolomic imaging of prostate cancer with magnetic resonance spectroscopy and mass spectrometry.Evaluation of lactate and alanine as metabolic biomarkers of prostate cancer using 1H HR-MAS spectroscopy of biopsy tissues.Clinical applications of metabolomics in oncology: a review.Advances in MR spectroscopy of the prostate.A hierarchical spectral clustering and nonlinear dimensionality reduction scheme for detection of prostate cancer from magnetic resonance spectroscopy (MRS).Use of nuclear magnetic resonance-based metabolomics in detecting drug resistance in cancerMRI of the prostate: clinical relevance and emerging applications.Metabolomics: a novel approach to early and noninvasive prostate cancer detection.MRI & MRS assessment of the role of the tumour microenvironment in response to therapy.A decade in prostate cancer: from NMR to metabolomics.MRS and MRSI guidance in molecular medicine: targeting and monitoring of choline and glucose metabolism in cancer.Molecular imaging for personalized cancer care.Role of MRI in prostate cancer detection.Mapping of prostate cancer by 1H MRSI.Pitfalls in Interpreting mp-MRI of the Prostate: A Pictorial Review with Pathologic Correlation.PET and PET/CT with radiolabeled choline in prostate cancer: a critical reappraisal of 20 years of clinical studies.Fast acquisition-weighted three-dimensional proton MR spectroscopic imaging of the human prostate.Influence of androgen deprivation therapy on choline PET/CT in recurrent prostate cancer.Do we have to withdraw antiandrogenic therapy in prostate cancer patients before PET/CT with [11C]choline?
P2860
Q26996477-FE5DF4D1-C0BB-4BE3-B15E-39ED68C9151AQ31137179-7B5E3FEB-346B-4C96-A635-75378E357633Q33693035-E06A7C3B-938B-426F-9BA1-33D72552960EQ33823063-3B684B6D-24F9-46E9-81B1-CBC1C8D93081Q33849173-90822532-41D9-4A27-8245-872B3CF81251Q33881902-70804BB0-500C-4CD2-9AF6-917EC194899CQ34234941-71FDBE32-D911-470C-9242-AFEA94B111E1Q34585443-0C0BFCE5-652E-4BA9-AE55-ABD1F08C2F0AQ34918676-E0908465-CEAE-4EA4-ACED-71601E59CF65Q35700192-74BFE98F-E3B0-4798-87D9-054CE21B0278Q35746099-414E722F-E3DA-4CF0-849A-E41B9A49233EQ36128629-AA15F15B-999D-4F7B-A0BA-7C66BFB1F8FEQ36630017-62A6C3F1-616A-4084-83A5-D878AE396AADQ36638498-95E9D477-9DF2-4527-8E3F-139D1FD68F0FQ36670926-B343990D-980E-466E-97DA-A89C795B52B3Q36866123-A4B4FF4E-C89D-4B0E-A848-F07F3A377A99Q36949577-CAD26BB1-7799-4BDA-A2BA-C240399E0CC2Q37036880-49452ACE-6028-418F-8806-E23F9CBA1A03Q37177549-A27C3292-754D-43A0-8D4D-02B27C3DFEC2Q37300338-4F5690F8-E75E-429D-8690-A5C8176C6788Q37335007-DD6C978D-2704-4C47-88CA-B5EEE5A544B7Q37374479-E5BC8BF5-723E-4782-8745-3E64D5CC699FQ37833011-2D947665-5582-4D08-AA29-D621EEBC6BCBQ37850315-8D999178-420A-42E6-B9DF-01882A0DC255Q37875004-820D4FB2-BF4B-4BFB-95F2-4BBE6603A6F7Q37876681-F71256EE-E215-48A2-B865-C6F2C886E3A5Q37906482-AB633757-FD6B-48C0-BC9B-FF88B72299AEQ37999206-4409F546-2527-434F-B60C-C3785059C311Q38089710-CC57D3B6-9259-499F-B9C8-8536BEA67F02Q38114017-570D3570-26F0-4670-8F03-678D2C0403A5Q38589371-935B53F7-453B-4DD1-9D05-06F2FD5A7FCEQ39242140-A18E5A63-E02E-4753-A491-AC752CB4832CQ44965424-CD1CE4F9-82CE-4736-9DFF-3C946759EFCDQ45384878-0713DEA1-5D52-4470-B7E0-ACE1C0ABD7ECQ53203687-BC547C45-B0EA-4D7D-8F6B-FA0945CB099B
P2860
Time-dependent effects of hormone-deprivation therapy on prostate metabolism as detected by combined magnetic resonance imaging and 3D magnetic resonance spectroscopic imaging.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Time-dependent effects of horm ...... sonance spectroscopic imaging.
@en
Time-dependent effects of horm ...... sonance spectroscopic imaging.
@nl
type
label
Time-dependent effects of horm ...... sonance spectroscopic imaging.
@en
Time-dependent effects of horm ...... sonance spectroscopic imaging.
@nl
prefLabel
Time-dependent effects of horm ...... sonance spectroscopic imaging.
@en
Time-dependent effects of horm ...... sonance spectroscopic imaging.
@nl
P2093
P2860
P356
P1476
Time-dependent effects of horm ...... sonance spectroscopic imaging.
@en
P2093
A Bessette
D B Vigneron
J Kurhanewicz
M G Swanson
P R Carroll
S J Nelson
P2860
P356
10.1002/MRM.1159
P577
2001-07-01T00:00:00Z